Brain-damaging vaccines, pesticides and medicines generate nearly $800 billion a year in medical revenues
Mounting evidence point to certain medications as risk factors in developing some of the most debilitating neurological conditions in the country. A study published in the JAMA Internal Medicine found a correlation between long-term use of anticholinergic medications like Benadryl and the onset of dementia. Anticholinergic drugs were shown to inhibit the action of acetylcholine, an organic chemical that plays a crucial role in learning and memory.
Researchers at the University of Washington examined nearly 3,500 men and women ages 65 years and older and found those who used anticholinergic drugs had higher odds of developing dementia than those who did not take the drug. Study data also showed that higher dementia risk coincided with cumulative doses of anticholinergic drugs. Researchers said patients who took the drugs for an equivalent of three years or more had a 54% increased odds of developing the mental disorder.
Potentially toxic substances found in vaccines may also play a key role in the development of brain damage. For instance, traces of aluminum in vaccines were linked to the Alzheimer’s disease and other neurological conditions. Aluminum, a toxic metal and a known neurotoxin, is often used as an adjuvant agent vaccines. A 2013 study published in the journal Immunologic Research revealed that adults with high aluminum exposure may were at an increased risk of developing age-related neurological conditions that resemble Alzheimer’s disease.